Jault F, Nataf P, Rama A, Fontanel M, Vaissier E, Pavie A, Bors V, Cabrol C, Gandjbakhch I
Department of Thoracic and Cardiovascular Surgery, Pitie's Hospital, Paris, France.
J Thorac Cardiovasc Surg. 1994 Oct;108(4):747-54.
Between January 1979 and December 1991, we operated on 339 patients for chronic disease of the ascending aorta. The operation was elective in all. Endocarditis and its sequelae have been excluded. Thirty-one patients had a previous operation on the ascending aorta or the aortic valve; 268 patients had aneurysms of the ascending aorta without dissection; 72 had chronic aortic dissections, of whom 33 had a preexistent aneurysm. The patients included 272 men and 67 women. Mean age was 53.58 +/- 7 years. Eight percent of the patients had clinical stigmata of Marfan's disease. A tubular graft replacement was used in 7 patients, a tubular graft and valve replacement in 72 patients, and a composite valve graft replacement with reattachment of the coronary arteries using a 8 mm Dacron graft was performed in 260 patients. Concomitant procedures were used in 74 patients: coronary artery bypass grafts in 25, mitral valve replacement in 9, and aortic arch reconstruction in 40. The 30-day mortality rate was 7.6% (n = 26). For the whole group, multivariate analysis using stepwise logistic regression showed that operative risk factors were concomitant coronary artery bypass grafting, age (increased), aortic valve regurgitation, and previous cardiac surgery. Follow-up was conducted in 303 patients, and risk factors for late mortality were studied. Long-term survival was 59.6% +/- 3.7% at 9 years. It was 67% +/- 3.5% at 9 years for patients without aortic arch reconstruction and 56% +/- 4.5% for patients with aortic arch reconstruction (p = 0.0018). Reoperation was needed in 14 patients. Actuarial freedom from reoperation was 90% +/- 0.2% at 9 years for all the patients. Only one patient with composite valve graft replacement and reattachment of the coronary arteries had required reoperation for problems related to this procedure. This technique is used routinely by our team, especially in patients with large chronic aneurysms, dissected or not, and in those who had previous operations. The long-term results are good.
1979年1月至1991年12月期间,我们对339例升主动脉慢性病患者进行了手术。所有手术均为择期手术。已排除心内膜炎及其后遗症。31例患者曾接受过升主动脉或主动脉瓣手术;268例患者有升主动脉瘤但无夹层;72例有慢性主动脉夹层,其中33例术前存在动脉瘤。患者包括272名男性和67名女性。平均年龄为53.58±7岁。8%的患者有马凡综合征的临床体征。7例患者采用管状移植物置换,72例患者采用管状移植物和瓣膜置换,260例患者采用复合瓣膜移植物置换并使用8mm涤纶移植物重新附着冠状动脉。74例患者采用了同期手术:25例行冠状动脉搭桥术,9例行二尖瓣置换术,40例行主动脉弓重建术。30天死亡率为7.6%(n = 26)。对于整个组,使用逐步逻辑回归进行多变量分析表明,手术风险因素为同期冠状动脉搭桥术、年龄(增加)、主动脉瓣反流和既往心脏手术。对303例患者进行了随访,并研究了晚期死亡的风险因素。9年时长期生存率为59.6%±3.7%。未进行主动脉弓重建的患者9年时为67%±3.5%,进行主动脉弓重建的患者为56%±4.5%(p = 0.0018)。14例患者需要再次手术。所有患者9年时再次手术的精算自由度为90%±0.2%。只有1例采用复合瓣膜移植物置换并重新附着冠状动脉的患者因该手术相关问题需要再次手术。我们团队常规使用这种技术,特别是在患有大型慢性动脉瘤(无论是否有夹层)以及既往接受过手术的患者中。长期效果良好。